- Home
- TFSL vs ALVO Comparison
TFSL vs ALVO Comparison
Compare TFSL & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TFSL
- ALVO
- Stock Information
- Founded
- TFSL 1938
- ALVO 2013
- Country
- TFSL United States
- ALVO Luxembourg
- Employees
- TFSL N/A
- ALVO N/A
- Industry
- TFSL Savings Institutions
- ALVO Biotechnology: Pharmaceutical Preparations
- Sector
- TFSL Finance
- ALVO Health Care
- Exchange
- TFSL Nasdaq
- ALVO Nasdaq
- Market Cap
- TFSL 3.3B
- ALVO 3.4B
- IPO Year
- TFSL 2007
- ALVO N/A
- Fundamental
- Price
- TFSL $12.23
- ALVO $8.29
- Analyst Decision
- TFSL Hold
- ALVO Buy
- Analyst Count
- TFSL 2
- ALVO 1
- Target Price
- TFSL $14.50
- ALVO $18.00
- AVG Volume (30 Days)
- TFSL 459.3K
- ALVO 162.8K
- Earning Date
- TFSL 04-29-2025
- ALVO 05-20-2025
- Dividend Yield
- TFSL 9.24%
- ALVO N/A
- EPS Growth
- TFSL 14.86
- ALVO N/A
- EPS
- TFSL 0.29
- ALVO N/A
- Revenue
- TFSL $304,584,000.00
- ALVO $491,978,000.00
- Revenue This Year
- TFSL N/A
- ALVO $33.92
- Revenue Next Year
- TFSL $5.53
- ALVO $45.74
- P/E Ratio
- TFSL $42.59
- ALVO N/A
- Revenue Growth
- TFSL 0.99
- ALVO 426.85
- 52 Week Low
- TFSL $11.29
- ALVO $7.35
- 52 Week High
- TFSL $15.00
- ALVO $14.76
- Technical
- Relative Strength Index (RSI)
- TFSL 50.58
- ALVO 32.92
- Support Level
- TFSL $11.32
- ALVO $8.25
- Resistance Level
- TFSL $12.21
- ALVO $8.98
- Average True Range (ATR)
- TFSL 0.40
- ALVO 0.55
- MACD
- TFSL 0.05
- ALVO -0.01
- Stochastic Oscillator
- TFSL 75.81
- ALVO 36.86
About TFSL TFS Financial Corporation
TFS Financial Corp is the holding company for the Third Federal Savings and Loan Association of Cleveland. The company's ownership in the savings and loan association is its primary business activity. The association's principal business consists of originating and servicing residential real estate mortgage loans and attracting retail savings deposits. It does so by offering products with competitive rates and yields. The company also operates Third Capital, a wholly owned subsidiary that serves as a holding company or as an investor in vehicles such as private equity funds. Third Capital has interests in lease transactions of commercial buildings, title agencies providing escrow and settlement services, and reinsurance of private mortgage insurance on residential loans.
About ALVO Alvotech
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to proven treatments for various diseases.